Skip to content

13F-HR filed by Sio Capital Management, LLC

Sio Capital Management, LLC filed this 13F-HR for the quarter ended 2016-09-30, filed 2016-11-15, with 32 holding rows worth $145,003,000.

Accession
0001214659-16-014679
Filed
2016-11-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2016

A holdings report, 32 entries on the cover page, a total value of $145,003,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $145,003,000 with VALUE read as thousands by filing date, 13F file number 028-13691. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
QUOTIENT LTDG73268107SHS2,185,669$17,092,000thousands by filing date
Amgen Inc.031162100COM91,300$15,230,000thousands by filing datecall
KONINKLIJKE PHILIPS N V NY REGIS SHS NEW500472303ADR462,662$13,690,000thousands by filing date
CARDINAL HEALTH INC14149Y108COM133,937$10,407,000thousands by filing date
SANOFI SA SPONSORED ADR80105N105ADR223,380$8,531,000thousands by filing date
TABULA RASA HEALTHCARE INC873379101COMMON STOCK510,000$7,303,000thousands by filing date
ATHENAHEALTH INC04685W103COMMON STOCK57,600$7,265,000thousands by filing dateput
MEDICINES CO584688105COM179,700$6,782,000thousands by filing datecall
SAREPTA THERAPEUTICS INC803607100COM86,500$5,312,000thousands by filing dateput
HILL ROM HLDGS INC431475102COM61,299$3,799,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK1,020,719$3,746,000thousands by filing date
CHEMOCENTRYX INC16383L106COM613,890$3,708,000thousands by filing date
CERNER CORP156782104COM60,000$3,705,000thousands by filing dateput
PERRIGO CO PLC SHSG97822103Stock38,953$3,597,000thousands by filing date
MEDPACE HLDGS INC COM58506Q109Stock116,053$3,465,000thousands by filing date
ABBVIE INC00287Y959COM50,000$3,154,000thousands by filing dateput
ADVANCED ACCELERATOR APPLIC SPONSORED ADS00790T100ADR75,557$2,877,000thousands by filing date
ANTHERA PHARMACEUTCLS INC03674U201Common equity shares901,115$2,839,000thousands by filing date
ADAMIS PHARMACEUTICALS CORP00547W208COM NEW665,455$2,283,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR112,497$2,261,000thousands by filing date
NATUS MEDICAL INC639050103COM56,000$2,200,000thousands by filing date
ACETO CORP004446100COM115,781$2,199,000thousands by filing date
ACTINIUM PHARMACEUTICALS INC00507W107COM1,600,000$2,160,000thousands by filing date
UnitedHealth Group Inc91324P102COM15,049$2,107,000thousands by filing date
COHERUS ONCOLOGY INC19249H103COM73,053$1,956,000thousands by filing date
FORWARD PHARMA A/S34986J105SPONSORED ADR85,108$1,786,000thousands by filing date
ALMOST FAMILY INC020409108COM36,479$1,341,000thousands by filing date
VIKING THERAPEUTICS INC92686J106COM849,905$1,191,000thousands by filing date
ADAMAS PHARMACEUTICALS INC00548A106COM66,110$1,085,000thousands by filing date
AEGLEA BIOTHERAPEUTICS INC00773J103COM154,332$989,000thousands by filing date
PFENEX INC717071104COM64,556$578,000thousands by filing date
OASMIA PHARMACEUTICAL AB67421W109ADR122,100$365,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001214659-16-014679this filing2016-11-15acceptance time not in the bulk data set